Rocket Lab: Is It Finally Time to Buy Below $60?

RKLB has dropped below $60 after the company pushed its Neutron rocket launch to 2027, citing a propellant dome defect. The delay pushes the company's flagship medium-lift vehicle out on the calendar and has driven the sharp selloff.

The bullish counterweight is on the order book. Rocket Lab carries a $2.36 billion backlog and recently signed its largest commercial Electron deal. Both data points point to demand for the company's existing launch business that doesn't depend on Neutron's timeline.

The Motley Fool frames the pullback as an attractive entry point for long-term investors, with RKLB trading at 27x forward revenue estimates. That multiple is the number the bull case rests on. Our interpretation: the market is repricing the timeline risk on Neutron, while the backlog and the Electron contract suggest near-term revenue visibility remains intact. Whether 27x forward revenue is cheap depends on how much of the growth story the market still attributes to Neutron, and a 2027 launch date stretches that portion of the thesis further out.

The setup is a classic delay-driven drawdown: a hardware defect hits sentiment while contracted business stays in place.